Skip to search.
 TSX Up 0.16% TSX Ventures Down 0.30%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
406.36 Down 12.74(3.04%) Sep 29, 4:00PM EDT
|After Hours : 406.00 Down 0.36 (0.09%) Sep 29, 6:17PM EDT
Prev Close:419.10
Open:419.05
Bid:405.00 x 100
Ask:414.00 x 100
1y Target Est:467.86
Beta:1.39963
Earnings Date:Nov 2 - Nov 7 (Est.)
Day's Range:404.60 - 421.77
52wk Range:329.09 - 592.59
Volume:594,172
Avg Vol (3m):759,625
Market Cap:43.61B
P/E (ttm):63.39
EPS (ttm):6.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 3.04%43.61B
AMGNDown 2.51%123.82B

Key Statistics

Forward P/E (1 yr):27.99
P/S (ttm):9.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :11.00
Quarterly EPS Est (Sep-16) :2.73
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):2.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback